Ah-Leen Rayner
Ah-Leen Rayner is the chief executive of the Breast Cancer Foundation in New Zealand, who has been vocal about the urgent need for funding for the immunotherapy drug Keytruda, particularly for early-stage triple negative breast cancer patients. With a deep understanding of the challenges faced by women diagnosed with this aggressive form of cancer, Rayner advocates for better healthcare policies and access to vital treatments that could save lives.
Not in the pool (under ¢1).
Recent news mentions
Rayner is the CEO of Breast Cancer Foundation NZ advocating for funded access to more treatment options for high-risk early-stage triple negative breast cancer patients.
Auckland woman’s plea to Parliament over hidden costs of breast cancer treatment
New Zealand· 2025-10-23
Ah-Leen Rayner, chief executive of Breast Cancer Foundation NZ, was blown away by the response to the video.
Why is NZ Blood making TikToks about breasts, and why are they going viral?New Zealand· 2025-10-07
Ah-Leen Rayner is the CEO of the Breast Cancer Foundation NZ and has commented on the importance of Keytruda.
Auckland woman paying $85k for cancer treatment petitions Government for fundingNew Zealand· 2025-07-01
Rayner is the chief executive of the Breast Cancer Foundation New Zealand, advocating for the funding of Enhertu.
Breast cancer: Pāpāmoa retiree with ‘incurable’ diagnosis calls for Enhertu drug fundingNew Zealand· 2025-06-09
Ah-Leen Rayner is the CEO of the Breast Cancer Foundation NZ.
A vision for NZ: A safe place where everyone can prosper - Bruce CotterillNew Zealand· 2025-06-07
Ah-Leen Rayner is the chief executive of Breast Cancer Foundation NZ.
Taranaki mum Stacey Winiata diagnosed with breast cancer after giving birth to twinsNew Zealand· 2025-04-25
Ah-Leen Rayner, chief executive of the Breast Cancer Foundation, discusses the need for funding Keytruda for breast cancer treatment.
Auckland woman in her 50s selling her home to pay for unfunded breast cancer treatment costing $85kNew Zealand· 2025-02-28
